Pain Management Device Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product (Electrical Stimulators, Radiofrequency Ablation (RFA), Analgesic Infusion Pumps, Neurostimulation), By Mode of Purchase (Over-The-Counter, Prescription-Based), By Application (Cancer, Neuropathic Pain, Facial & Migraine, Musculoskeletal Disorder, Others), By End User (Hospitals & Clinics, Physiotherapy Centers, Others), By Region, By competition, 2020-2030F

Market Overview

The Global Pain Management Device Market, valued at USD 6.96 Billion in 2024, is projected to experience a CAGR of 9.37% to reach USD 11.91 Billion by 2030. Pain management devices encompass a range of medical technologies specifically engineered to alleviate or control various types of pain, utilizing mechanisms such as electrical stimulation, thermal therapy, and targeted drug delivery systems. The global market for these devices is primarily driven by the escalating prevalence of chronic pain conditions worldwide, the demographic shift towards an aging global population, and a growing patient preference for non-opioid pain management solutions. According to the International Association for the Study of Pain, in 2023, approximately 20% of adults in the Western world reported experiencing chronic pain, underscoring a substantial patient base requiring sustained pain management interventions.

Further propelling market expansion are continuous technological advancements that enhance device efficacy and patient outcomes. However, the high product and procedural costs associated with advanced pain management devices present a significant impediment to broader market adoption and accessibility, particularly in developing regions.

Key Market Drivers

The global pain management device market is significantly influenced by ongoing technological advancements that introduce more effective and patient-centric solutions. Innovations are continuously improving device efficacy, miniaturization, and integration with digital health platforms, thereby enhancing patient outcomes and expanding therapeutic applications. For instance, according to Medtronic's Q4 2024 earnings report, in May 2024, the company announced U. S. FDA approval for its Inceptiv closed-loop spinal cord stimulator, a system designed to automatically sense and adjust stimulation 50 times a second, offering more personalized and consistent chronic pain therapy. This continuous evolution in device capabilities attracts both healthcare providers seeking superior treatment modalities and patients desiring advanced, less burdensome pain management options.

Further propelling market expansion is the increasing demand for non-opioid pain management solutions, driven by heightened awareness of opioid risks and a preference for safer alternatives. This shift has accelerated the adoption of device-based therapies such as neurostimulation, radiofrequency ablation, and targeted drug delivery systems, which provide effective pain relief without the addictive potential of opioids. According to the American Society of Interventional Pain Physicians, in 2023, the cost of medical equipment, supplies, and technology, much of which supports interventional and non-opioid pain procedures, reached $57 billion, growing at an average annual rate of 6.5% since 2017. The broader market for pain management devices also reflects substantial industry commitment; according to Fierce Medtech, in October 2024, Medtronic, a leading medical device company, invested $2.735 billion in research and development in 2023, representing approximately 8.45% of its revenue, underscoring ongoing efforts to innovate and address unmet patient needs in pain relief.

Download Free Sample Report

Key Market Challenges

High product and procedural costs associated with advanced pain management devices present a significant impediment to broader market adoption and accessibility. These elevated expenditures directly limit the ability of healthcare systems and individual patients to acquire and utilize essential pain management technologies, particularly within developing regions where healthcare budgets are often constrained. This financial barrier restricts market penetration, preventing a substantial patient base from accessing sustained pain management interventions.

According to AdvaMed, a prominent medical technology association, a survey of healthcare supply chain professionals released in early 2025 indicated that 80% anticipated increased import expenses would raise costs by at least 15% for hospitals and health systems. This directly translates into higher operational costs for providers, impacting the affordability and availability of advanced medical devices, including those for pain management. Consequently, the global pain management device market experiences hampered growth due to reduced accessibility and limited procurement capacities in numerous underserved areas.

Key Market Trends

Two significant trends shaping the Global Pain Management Device Market are the integration of Artificial Intelligence into device functionality and treatment, and the rising adoption of wearable and portable pain relief devices. These trends introduce enhanced capabilities and broader accessibility for patients.

The integration of artificial intelligence in device functionality and treatment is fundamentally transforming pain management through adaptive therapies and predictive analytics. AI algorithms enable devices to learn from patient data, personalize stimulation parameters, and anticipate pain patterns, leading to more tailored and effective interventions. As of May 2024, the U. S. FDA approved 882 devices powered by artificial intelligence and machine learning, demonstrating a clear industry shift towards intelligent medical technologies. This not only improves patient outcomes but also streamlines clinical workflows, making advanced pain therapies more efficient. For instance, in March 2023, Medtronic partnered with NVIDIA Corporation to build an AI platform for medical devices, underscoring the industry's commitment to leveraging artificial intelligence for next-generation solutions.

The rising adoption of wearable and portable pain relief devices represents another influential trend, driven by patient demand for convenience, discretion, and at-home management options. These devices offer non-invasive solutions for a range of chronic pain conditions, facilitating continuous monitoring and therapy delivery outside traditional clinical settings. In February 2024, the U. S. FDA authorized the X-trades System M, a wireless wearable device for electrophysiological monitoring, illustrating regulatory support for these accessible technologies. This trend empowers patients to take a more active role in their pain management. NeuroMetrix, a developer of wearable devices, reported that its Quell revenue for fibromyalgia increased by 47% in the second quarter of 2024 from the second quarter of 2023, highlighting the growing market acceptance and demand for such portable solutions.

Segmental Insights

The Cancer segment is experiencing rapid growth in the Global Pain Management Device Market due to the escalating incidence of cancer worldwide and the associated severe, persistent pain that requires effective management for improved patient quality of life. This growth is further propelled by advancements in pain control therapies, including innovative devices that offer targeted pain relief and a shift towards non-opioid alternatives. The increasing demand for palliative care services and specialized cancer care clinics, which efficiently adapt to changing patient conditions, also contributes significantly to this expansion. Regulatory bodies like the U. S. Food and Drug Administration (FDA) play a crucial role in approving and overseeing the safety and effectiveness of these evolving pain management technologies.

Regional Insights

North America holds the leading position in the global pain management device market, primarily owing to its advanced and extensive healthcare infrastructure that provides readily available access to cutting-edge pain management technologies. The region's market leadership is further propelled by the high prevalence of various chronic pain conditions, including neuropathic and musculoskeletal disorders, impacting a substantial portion of the population. Favorable reimbursement policies and comprehensive insurance coverage significantly support the widespread adoption of these devices across the region. Additionally, continuous technological advancements and the strong presence of major medical device companies contribute to North America's sustained dominance in the global pain management device sector.

Recent Developments

• In July 2025, Neuros Medical, Inc. achieved a key milestone with the first commercial implantation of its FDA-approved Altius® Direct Electrical Nerve Stimulation System in the U.S. This pioneering device is specifically designed to manage chronic post-amputation pain, including phantom and residual limb pain, for lower limb amputees. The Altius System provides patient-controlled, on-demand direct electrical nerve stimulation, offering a non-opioid treatment alternative. This launch addresses a significant need in the Global Pain Management Device Market by offering durable pain relief and improving the quality of life for amputees.

• In July 2025, Saluda Medical, Inc. announced the full commercial launch of its EVA™ sensing technology in the United States, compatible with the Evoke® SmartLoop™ System for chronic pain management. This next-generation sensing technology objectively scans and analyzes a patient's spinal cord, delivering personalized therapy with enhanced precision. EVA automates manual programming steps, optimizing patient outcomes by sensing, measuring, and adjusting stimulation based on real-time neural response biomarkers. This breakthrough in closed-loop neuromodulation signifies a notable advancement within the Global Pain Management Device Market, aiming to improve reliability and reproducibility of patient results.

• In April 2024, Medtronic plc received U.S. Food and Drug Administration (FDA) approval for its Inceptiv™ closed-loop rechargeable spinal cord stimulator (SCS), a significant advancement in the Global Pain Management Device Market. This innovative device automatically adjusts electrical pulses in real-time by sensing biological signals along the spinal cord, preventing uncomfortable overstimulation that can occur with patient movements like sneezing or bending. The Inceptiv system, which is also the smallest and thinnest fully implantable SCS device, offers a more personalized and comfortable experience for individuals suffering from chronic pain, representing a breakthrough in neuromodulation therapy.

• In February 2024, Boston Scientific Corporation announced that its WaveWriter™ Spinal Cord Stimulator (SCS) Systems received U.S. Food and Drug Administration (FDA) approval for an expanded indication. This approval allows the system to treat chronic low back and leg pain in individuals who have not undergone prior back surgery, addressing a significant unmet need in the Global Pain Management Device Market. The expanded use is supported by positive one-year data from the SOLIS randomized control trial, which demonstrated substantial and sustained pain relief for patients. This development aims to provide new treatment options beyond conventional medical management.

Key Market Players

• Medtronic Plc
• Boston Scientific Corporation
• Stryker Corporation
• Kennedy Lewis Management LP
• ICU Medical Inc
• Enovis
• Baxter International Inc
• LivaNova PLC
• Abbott Laboratories Inc
• DJO Global LLC

Report Scope:

In this report, the Global Pain Management Device Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

• Pain Management Device Market, By Product:

o   Electrical Stimulators

o   Radiofrequency Ablation (RFA)

o   Analgesic Infusion Pumps

o   Neurostimulation

• Pain Management Device Market, By Mode of Purchase:

o   Over The Counter

o   Prescription-Based

• Pain Management Device Market, By Application:

o   Cancer

o   Neuropathic Pain

o   Facial & Migraine

o   Musculoskeletal Disorder

o   Others

• Pain Management Device Market, By End User:

o   Hospitals & Clinics

o   Physiotherapy Centers

o   Others

• Pain Management Device Market, By Region:

o   North America

§  United States

§  Canada

§  Mexico

o   Europe

§  France

§  United Kingdom

§  Italy

§  Germany

§  Spain

o   Asia Pacific

§  China

§  India

§  Japan

§  Australia

§  South Korea

o   South America

§  Brazil

§  Argentina

§  Colombia

o   Middle East & Africa

§  South Africa

§  Saudi Arabia

§  UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Pain Management Device Market.

Available Customizations:

Global Pain Management Device Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Global Pain Management Device Market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected]